Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage

NAUnknownINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

June 29, 2014

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2024

Conditions
Ovarian CancerOvarian CarcinomaFallopian Tube CancerPrimary Peritoneal CarcinomaSerous Cystadenocarcinoma
Interventions
PROCEDURE

Uterine lavage

Uterine lavage is performed using an intrauterine insemination catheter or rigid pipelle uterine sampler. The catheter is inserted into the cervical canal. 10mL of saline are infused into the uterine cavity and fallopian tubes and immediately retrieved.

PROCEDURE

Blood sample

5-10mL of blood will be drawn from participants.

DEVICE

Uterine lavage catheter

Uterine lavage is performed using an intrauterine insemination catheter or rigid pipelle uterine sampler. The catheter is inserted into the cervical canal. 10mL of saline are infused into the uterine cavity and fallopian tubes and immediately retrieved.

Trial Locations (4)

44281

RECRUITING

Meir Medical Center, Kfar Saba

49414

RECRUITING

Rabin Medical Center, Petah Tikva

52621

RECRUITING

Sheba Medical Center, Ramat Gan

91031

NOT_YET_RECRUITING

Shaare Zedek Medical Center, Jerusalem

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Rabin Medical Center

OTHER

collaborator

Meir Medical Center

OTHER

collaborator

Shaare Zedek Medical Center

OTHER

lead

Sheba Medical Center

OTHER_GOV